Liraglutide and its Neuroprotective Properties—Focus on Possible Biochemical Mechanisms in Alzheimer’s Disease and Cerebral Ischemic Events
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liraglutide and its Neuroprotective Properties—Focus on Possible Biochemical Mechanisms in Alzheimer’s Disease and Cerebral Ischemic Events
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 5, Pages 1050
Publisher
MDPI AG
Online
2019-03-01
DOI
10.3390/ijms20051050
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease
- (2018) Andre F Batista et al. JOURNAL OF PATHOLOGY
- The role of Rho-kinase and calcium ions in constriction triggered by ET-1
- (2018) Michał Wiciński et al. MICROVASCULAR RESEARCH
- Liraglutide Activates the Nrf2/HO-1 Antioxidant Pathway and Protects Brain Nerve Cells against Cerebral Ischemia in Diabetic Rats
- (2018) Caihong Deng et al. Computational Intelligence and Neuroscience
- Subcutaneous Administration of Liraglutide Ameliorates Alzheimer-Associated Tau Hyperphosphorylation in Rats with Type 2 Diabetes1
- (2018) Yan Yang et al. JOURNAL OF ALZHEIMERS DISEASE
- Neuroprotective Activity of Sitagliptin via Reduction of Neuroinflammation beyond the Incretin Effect: Focus on Alzheimer’s Disease
- (2018) Michał Wiciński et al. Biomed Research International
- Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology
- (2018) Martina Holubová et al. NEUROPHARMACOLOGY
- Beneficial Effects of Resveratrol Administration—Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions
- (2018) Michał Wiciński et al. Nutrients
- cAMP/PKA signaling pathway contributes to neuronal apoptosis via regulating IDE expression in a mixed model of type 2 diabetes and Alzheimer's disease
- (2017) Huajie Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Insulin deficiency results in reversible protein kinase A activation and tau phosphorylation
- (2017) Judith M. van der Harg et al. NEUROBIOLOGY OF DISEASE
- Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells
- (2017) Dimitra Zagoura et al. NEUROCHEMISTRY INTERNATIONAL
- Delayed administration of the GLP-1 receptor agonist liraglutide improves metabolic and functional recovery after cerebral ischemia in rats
- (2017) Wenbin Dong et al. NEUROSCIENCE LETTERS
- Resveratrol Increases Serum BDNF Concentrations and Reduces Vascular Smooth Muscle Cells Contractility via a NOS-3-Independent Mechanism
- (2017) Michał Wiciński et al. Biomed Research International
- Liraglutide modulates GABAergic signaling in rat hippocampal CA3 pyramidal neurons predominantly by presynaptic mechanism
- (2017) Omar Babateen et al. BMC Pharmacology & Toxicology
- Nrf2/antioxidant defense pathway is involved in the neuroprotective effects of Sirt1 against focal cerebral ischemia in rats after hyperbaric oxygen preconditioning
- (2016) Fen Xue et al. BEHAVIOURAL BRAIN RESEARCH
- The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice
- (2016) Ping-Chia Li et al. BMC NEUROSCIENCE
- The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy
- (2016) Henrik H. Hansen et al. BRAIN RESEARCH
- Executive Summary: Heart Disease and Stroke Statistics—2016 Update
- (2016) Dariush Mozaffarian et al. CIRCULATION
- Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
- (2016) Michael A. Gimbrone et al. CIRCULATION RESEARCH
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model
- (2016) Liqin Qi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pericytes of the neurovascular unit: key functions and signaling pathways
- (2016) Melanie D Sweeney et al. NATURE NEUROSCIENCE
- A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat
- (2016) Ling Han et al. NEUROREPORT
- The Modulatory Effect of Ischemia and Reperfusion on Arginine Vasopressin-Induced Arterial Reactions
- (2016) Katarzyna Szadujkis-Szadurska et al. Biomed Research International
- The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K/AKT and MAPK Pathways
- (2016) Huili Zhu et al. Scientific Reports
- Oxymatrine ameliorates renal ischemia-reperfusion injury from oxidative stress through Nrf2/HO-1 pathway
- (2015) Guanjun Jiang et al. Acta Cirurgica Brasileira
- The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease
- (2015) Huiting Gao et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Glucagon-like peptide-1 receptor agonists inhibit hepatic stellate cell activation by blocking the p38 MAPK signaling pathway
- (2015) L.K. Wu et al. GENETICS AND MOLECULAR RESEARCH
- Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice
- (2015) De-Lin Ma et al. JOURNAL OF NEUROCHEMISTRY
- Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways
- (2015) C. Bohm et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling
- (2015) Natura Myeku et al. NATURE MEDICINE
- Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain
- (2015) Simon C. Cork et al. Molecular Metabolism
- The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration
- (2014) David Heras-Sandoval et al. CELLULAR SIGNALLING
- Liraglutide for the treatment of type 2 diabetes
- (2014) D Shyangdan et al. HEALTH TECHNOLOGY ASSESSMENT
- Protective Action of Liraglutide in Beta Cells Under Lipotoxic Stress Via PI3K/Akt/FoxO1 Pathway
- (2014) Shiying Shao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia
- (2014) S. Briyal et al. NEUROSCIENCE
- A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis
- (2014) Yuko Tashiro et al. PEPTIDES
- Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
- (2014) Fares Bassil et al. PROGRESS IN NEUROBIOLOGY
- Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Classification and Vascular Territory of Ischemic Stroke Lesions Diagnosed by Diffusion‐Weighted Imaging
- (2014) Jong‐Won Chung et al. Journal of the American Heart Association
- Glucagon-like Peptide-1 Receptor Agonist Liraglutide Inhibits Endothelin-1 in Endothelial Cell by Repressing Nuclear Factor-Kappa B Activation
- (2013) Yao Dai et al. CARDIOVASCULAR DRUGS AND THERAPY
- The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse model
- (2013) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- Neuroprotective Effects of Liraglutide for Stroke Model of Rats
- (2013) Kenichiro Sato et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Alzheimer’s disease and insulin resistance: translating basic science into clinical applications
- (2013) Fernanda G. De Felice JOURNAL OF CLINICAL INVESTIGATION
- Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
- (2013) Paula L. McClean et al. NEUROPHARMACOLOGY
- The Insulin-Like Growth Factor 1 Receptor Is Essential for Axonal Regeneration in Adult Central Nervous System Neurons
- (2013) Sebastián Dupraz et al. PLoS One
- Chronic Treatment with the GLP1 Analogue Liraglutide Increases Cell Proliferation and Differentiation into Neurons in an AD Mouse Model
- (2013) Vadivel Parthsarathy et al. PLoS One
- Oxygen Consumption and Usage During Physical Exercise: The Balance Between Oxidative Stress and ROS-Dependent Adaptive Signaling
- (2012) Zsolt Radak et al. ANTIOXIDANTS & REDOX SIGNALING
- The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells
- (2012) Aya Shiraki et al. ATHEROSCLEROSIS
- Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
- (2012) Kerry Hunter et al. BMC NEUROSCIENCE
- Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders
- (2012) Isidro Salcedo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Metabolic Alterations Induced by Sucrose Intake and Alzheimer’s Disease Promote Similar Brain Mitochondrial Abnormalities
- (2012) Cristina Carvalho et al. DIABETES
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2
- (2012) K. D. Copps et al. DIABETOLOGIA
- Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis
- (2012) Suryakant K. Niture et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
- (2012) Konrad Talbot et al. JOURNAL OF CLINICAL INVESTIGATION
- GLP-1 secretion by microglial cells and decreased CNS expression in obesity
- (2012) Camilla Kappe et al. Journal of Neuroinflammation
- NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
- (2012) Michael T. Heneka et al. NATURE
- Injury and repair in the neurovascular unit
- (2012) Changhong Xing et al. NEUROLOGICAL RESEARCH
- Role of the vascular endothelium and plaque in acute ischemic stroke
- (2012) J. A. Madden NEUROLOGY
- Mechanisms Underlying Insulin Deficiency-Induced Acceleration of β-Amyloidosis in a Mouse Model of Alzheimer's Disease
- (2012) Latha Devi et al. PLoS One
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
- (2011) Haitao Wen et al. NATURE IMMUNOLOGY
- Glucose tolerance status and risk of dementia in the community: The Hisayama Study
- (2011) T. Ohara et al. NEUROLOGY
- Blood-Brain-Barrier Models for the Investigation of Transporter- and Receptor-Mediated Amyloid-β Clearance in Alzheimers Disease
- (2010) T. Pflanzner et al. Current Alzheimer Research
- Toward a comprehensive neurobiology of IGF-I
- (2010) Ignacio Torres-Aleman Developmental Neurobiology
- Population Pharmacokinetics of Liraglutide, a Once-Daily Human Glucagon-Like Peptide-1 Analog, in Healthy Volunteers and Subjects With Type 2 Diabetes, and Comparison to Twice-Daily Exenatide
- (2010) Estelle Watson et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Relationship between Caspase Activity and Apoptotic Markers in Human Sperm in Response to Hydrogen Peroxide and Progesterone
- (2010) Graciela M. LOZANO et al. JOURNAL OF REPRODUCTION AND DEVELOPMENT
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease
- (2010) Lars M. Ittner et al. NATURE REVIEWS NEUROSCIENCE
- The impact of dietary energy intake on cognitive aging
- (2010) Mattson Frontiers in Aging Neuroscience
- A simple role for BDNF in learning and memory?
- (2010) Cunha Frontiers in Molecular Neuroscience
- Study of the insulin signaling pathways in the regulation of ACAT1 expression in cultured macrophages☆
- (2009) Chen Xin et al. CELL BIOLOGY INTERNATIONAL
- Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease
- (2009) Binggui Sun et al. Cell Stem Cell
- Ciliary neurotrophic factor recruitment of glucagon-like peptide-1 mediates neurogenesis, allowing immortalization of adult murine hypothalamic neurons
- (2009) Denise D. Belsham et al. FASEB JOURNAL
- ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells
- (2009) Ji Cao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
- Incretin-based therapies for type 2 diabetes mellitus
- (2009) Julie A. Lovshin et al. Nature Reviews Endocrinology
- Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
- (2009) Alison Hamilton et al. NEUROREPORT
- Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
- (2008) M. Nauck et al. DIABETES CARE
- Targeting β-Cell Mass in Type 2 Diabetes: Promise and Limitations of New Drugs Based on Incretins
- (2008) Marzieh Salehi et al. ENDOCRINE REVIEWS
- Transthyretin binding to A-Beta peptide - Impact on A-Beta fibrillogenesis and toxicity
- (2008) R. Costa et al. FEBS LETTERS
- Evidence for Involvement of ERK, PI3K, and RSK in Induction of Bcl-2 by Valproate
- (2008) Thomas K. Creson et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain
- (2008) Itaru Imayoshi et al. NATURE NEUROSCIENCE
- Inhibition of LTP by beta-amyloid is prevented by activation of β2 adrenoceptors and stimulation of the cAMP/PKA signalling pathway
- (2008) Qin-wen Wang et al. NEUROBIOLOGY OF AGING
- Transthyretin Protects against A-Beta Peptide Toxicity by Proteolytic Cleavage of the Peptide: A Mechanism Sensitive to the Kunitz Protease Inhibitor
- (2008) Rita Costa et al. PLoS One
- Similarities and differences between insulin and IGF-I: Structures, receptors, and signalling pathways
- (2008) Haim Werner et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease
- (2007) Göran Bertilsson et al. JOURNAL OF NEUROSCIENCE RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search